Skip to main content
Top
Published in:

03-01-2024 | SARS-CoV-2 | LETTER TO THE EDITOR

Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia

Authors: Simona Leoni, Rayan Bou-Fakhredin, Francesca Granata, Elena Cassinerio, Marco Maggioni, Anna Ludovica Fracanzani, Maria Domenica Cappellini, Irene Motta

Published in: Annals of Hematology | Issue 3/2024

Login to get access

Excerpt

Dear Editor, …
Appendix
Available only for authorised users
Literature
1.
go back to reference Codoni G, Kirchner T, Engel B, Villamil AM, Efe C, Stattermayer AF et al (2023) Histological and serological features of acute liver injury after SARS-CoV-2 vaccination. JHEP Rep 5(1):100605CrossRefPubMed Codoni G, Kirchner T, Engel B, Villamil AM, Efe C, Stattermayer AF et al (2023) Histological and serological features of acute liver injury after SARS-CoV-2 vaccination. JHEP Rep 5(1):100605CrossRefPubMed
2.
go back to reference Patel AH, Amin R, Lalos AT (2022) Acute liver injury and IgG4-related autoimmune pancreatitis following mRNA-based COVID-19 vaccination. Hepatol Forum 3(3):97–99PubMedPubMedCentral Patel AH, Amin R, Lalos AT (2022) Acute liver injury and IgG4-related autoimmune pancreatitis following mRNA-based COVID-19 vaccination. Hepatol Forum 3(3):97–99PubMedPubMedCentral
3.
go back to reference Wong CKH, Mak LY, Au ICH, Lai FTT, Li X, Wan EYF et al (2022) Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines. J Hepatol 77(5):1339–1348CrossRefPubMedPubMedCentral Wong CKH, Mak LY, Au ICH, Lai FTT, Li X, Wan EYF et al (2022) Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines. J Hepatol 77(5):1339–1348CrossRefPubMedPubMedCentral
4.
go back to reference Efe C, Kulkarni AV, Terziroli Beretta-Piccoli B, Magro B, Stattermayer A, Cengiz M et al (2022) Liver injury after SARS-CoV-2 vaccination: features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. Hepatology 76(6):1576–1586CrossRefPubMed Efe C, Kulkarni AV, Terziroli Beretta-Piccoli B, Magro B, Stattermayer A, Cengiz M et al (2022) Liver injury after SARS-CoV-2 vaccination: features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. Hepatology 76(6):1576–1586CrossRefPubMed
5.
go back to reference Bril F, Al Diffalha S, Dean M, Fettig DM (2021) Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty? J Hepatol 75(1):222–224CrossRefPubMedPubMedCentral Bril F, Al Diffalha S, Dean M, Fettig DM (2021) Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty? J Hepatol 75(1):222–224CrossRefPubMedPubMedCentral
6.
go back to reference Kulkarni AV, Anders M, Nazal L, Ridruejo E, Efe C (2023) Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination. J Hepatol 78(2):e60–e61CrossRefPubMed Kulkarni AV, Anders M, Nazal L, Ridruejo E, Efe C (2023) Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination. J Hepatol 78(2):e60–e61CrossRefPubMed
7.
go back to reference Shroff H, Satapathy SK, Crawford JM, Todd NJ, VanWagner LB (2022) Liver injury following SARS-CoV-2 vaccination: a multicenter case series. J Hepatol 76(1):211–214CrossRefPubMed Shroff H, Satapathy SK, Crawford JM, Todd NJ, VanWagner LB (2022) Liver injury following SARS-CoV-2 vaccination: a multicenter case series. J Hepatol 76(1):211–214CrossRefPubMed
8.
go back to reference Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T et al (2020) A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia. N Engl J Med 382(13):1219–1231CrossRefPubMed Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T et al (2020) A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia. N Engl J Med 382(13):1219–1231CrossRefPubMed
Metadata
Title
Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia
Authors
Simona Leoni
Rayan Bou-Fakhredin
Francesca Granata
Elena Cassinerio
Marco Maggioni
Anna Ludovica Fracanzani
Maria Domenica Cappellini
Irene Motta
Publication date
03-01-2024
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 3/2024
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-023-05591-x

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more